Delivery Order SPE2DB20D3103-SPE2DB24FP5T3
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,917.62, is for the delivery of Lidocaine HCl 1% Vial 10mL to support military healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,731.76 firm-fixed-price delivery order is for the supply of 4560703404 - Lidocaine HCL 1% Vial 2ML, with a period of performance through April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a $1,366.67 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% Vial 50ML, a pharmaceutical product, with a period of performance through June 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Lidocaine HCl 1% vials. The award is a Firm Fixed Price contract with a ceiling value of $1,048.96 and a period of performance through August 5, 2024. This order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 for...
This federal contract award is for the delivery of Lidocaine HCL 1% in 10 ml vials, valued at $1,991.04, from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 30, 2024 and was awarded on April 29, 2024 with a firm fixed price. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Lidocaine HCL 1% ampules to the Defense Logistics Agency (DLA). The $1,224.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,963.60, is for the delivery of Lidocaine HCL 2% Luer-Jet 5ML, a medical product. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for...
This federal contract award, valued at $4,140.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the procurement of Lidocaine HCL 4% Solution, 4ML, a medical commodity used for various healthcare applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a...
This is a delivery order awarded to Amerisourcebergen Drug Corporation (Corporate Office Division) by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The $1,484.79 firm fixed-price contract is for the supply of lidocaine hydrochloride 2% vials, a critical medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...